• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Argan Reports Strong Earnings, Joins Geron, Planet Labs PBC And Other Big Stocks Moving Higher On Friday

    6/7/24 10:19:37 AM ET
    $AGX
    $BRZE
    $CRDO
    $CVNA
    Engineering & Construction
    Consumer Discretionary
    Computer Software: Prepackaged Software
    Technology
    Get the next $AGX alert in real time by email

    U.S. stocks were mixed, with the Dow Jones index gaining around 0.1% on Friday.

    Shares of Argan, Inc. (NYSE:AGX) rose sharply during Friday's session after the company reported better-than-expected first-quarter financial results.

    Argan posted quarterly earnings of 58 cents per share, beating market estimates of 52 cents per share. The company's quarterly sales came in at $157.68 million versus expectations of $134.75 million, according to data from Benzinga Pro.

    Argan shares climbed 11.1% to $76.78 on Thursday.

    Here are some other big stocks recording gains in today’s session.

    • Geron Corporation (NASDAQ:GERN) shares climbed 26% to $4.90 as the company reported the FDA approval of RYTELO™ (imetelstat), a first-in-class telomerase inhibitor, for the treatment of adult patients with lower-risk MDS with transfusion-dependent anemia.
    • SunPower Corporation (NASDAQ:SPWR) shares jumped 18.8% to $4.11.
    • Oddity Tech Ltd. (NASDAQ:ODD) rose 18.3% to $43.49 after the company approved a share buyback and raised its Q2 guidance.
    • Yext, Inc. (NYSE:YEXT) climbed 14.7% to $5.42. Yext is said to hire investment bankers to explore strategic alternatives, including a sale, Reuters reported.
    • Planet Labs PBC (NYSE:PL) climbed 9.6% to $1.9950 following better-than-expected quarterly earnings.
    • Limoneira Company (NASDAQ:LMNR) gained 9.4% to $22.27 as the company reported financial results for the second quarter ended April 30, 2024.
    • Esperion Therapeutics, Inc. (NASDAQ:ESPR) gained 8.7% to $2.6850.
    • Waldencast plc (NASDAQ:WALD) rose 8.6% to $4.77.
    • NWTN Inc. (NASDAQ:NWTN) climbed 8.5% to $2.17.
    • Dave Inc. (NASDAQ:DAVE) gained 7.8% to $39.57. B. Riley Securities analyst Hal Goetsch initiated coverage on Dave with a Buy rating and announced a price target of $60.
    • Mobileye Global Inc. (NASDAQ:MBLY) rose 7.6% to $29.48.
    • Credo Technology Group Holding Ltd (NASDAQ:CRDO) gained 7.2% to $27.72.
    • Braze, Inc. (NASDAQ:BRZE) gained 4.2% to $38.32 following better-than-expected first-quarter earnings.
    • Carvana Co. (NYSE:CVNA) rose 3.7% to $108.49.

    Now Read This: This Exxon Mobil Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

    Get the next $AGX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGX
    $BRZE
    $CRDO
    $CVNA

    CompanyDatePrice TargetRatingAnalyst
    Yext Inc.
    $YEXT
    3/11/2026$6.00Buy → Neutral
    Roth Capital
    ODDITY Tech Ltd.
    $ODD
    2/26/2026$23.00Outperform → In-line
    Evercore ISI
    ODDITY Tech Ltd.
    $ODD
    2/26/2026$16.00Overweight → Neutral
    Analyst
    ODDITY Tech Ltd.
    $ODD
    2/26/2026$13.00Equal Weight → Underweight
    Barclays
    ODDITY Tech Ltd.
    $ODD
    2/26/2026$10.00Buy → Underperform
    BofA Securities
    ODDITY Tech Ltd.
    $ODD
    2/25/2026Buy → Hold
    Needham
    ODDITY Tech Ltd.
    $ODD
    2/25/2026Buy → Hold
    Truist
    ODDITY Tech Ltd.
    $ODD
    2/25/2026$18.00Buy → Hold
    Jefferies
    More analyst ratings

    $AGX
    $BRZE
    $CRDO
    $CVNA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Yext downgraded by Roth Capital with a new price target

    Roth Capital downgraded Yext from Buy to Neutral and set a new price target of $6.00

    3/11/26 8:31:24 AM ET
    $YEXT
    EDP Services
    Technology

    ODDITY Tech Ltd. downgraded by Evercore ISI with a new price target

    Evercore ISI downgraded ODDITY Tech Ltd. from Outperform to In-line and set a new price target of $23.00

    2/26/26 8:34:26 AM ET
    $ODD
    Package Goods/Cosmetics
    Consumer Discretionary

    ODDITY Tech Ltd. downgraded by Analyst with a new price target

    Analyst downgraded ODDITY Tech Ltd. from Overweight to Neutral and set a new price target of $16.00

    2/26/26 7:11:50 AM ET
    $ODD
    Package Goods/Cosmetics
    Consumer Discretionary

    $AGX
    $BRZE
    $CRDO
    $CVNA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Smith Gary B bought $313 worth of shares (20 units at $15.66) and sold $254 worth of shares (20 units at $12.69) (SEC Form 4)

    4 - Planet Labs PBC (0001836833) (Issuer)

    2/3/26 6:35:28 PM ET
    $PL
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Director Slater Scott S bought $64,250 worth of shares (5,000 units at $12.85), increasing direct ownership by 8% to 64,447 units (SEC Form 4)

    4 - Limoneira CO (0001342423) (Issuer)

    1/9/26 4:01:10 PM ET
    $LMNR
    Farming/Seeds/Milling
    Consumer Staples

    Director Nolan Peter J bought $254,772 worth of shares (20,000 units at $12.74), increasing direct ownership by 2% to 1,133,862 units (SEC Form 4)

    4 - Limoneira CO (0001342423) (Issuer)

    1/6/26 4:01:15 PM ET
    $LMNR
    Farming/Seeds/Milling
    Consumer Staples

    $AGX
    $BRZE
    $CRDO
    $CVNA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    FOSTER CITY, Calif., March 18, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (NASDAQ:GERN), a commercial stage biopharmaceutical company, today reported that, effective March 17, 2026, it granted stock options to purchase an aggregate of 956,250 shares of common stock to six newly hired employees as an inducement material to such employees' acceptance of employment with Geron. The stock options have an exercise price of $1.62 per share, which is equal to the closing price of Geron's common stock on the grant date, have a ten-year term and vest over four years, with 12.5% of the shares underlying the options vesting on the six-month anniversary of commencement of employment of such employee a

    3/18/26 4:05:00 PM ET
    $GERN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Credo Introduces Robin 800G Optical DSP Family Tailored for Next Wave of AI Applications

    Highly Integrated, High-Performance and Power-Efficient Devices Bring Flexible Deployment Options to Accelerate AI Infrastructure Build-Out Credo Technology Group Holding Ltd (Credo) (NASDAQ:CRDO), an innovator in providing connectivity at scale through fast, reliable, and energy-efficient system solutions, today announced the launch of its Robin optical digital signal processor (DSP) family. The Robin optical DSP family is designed to meet the growing performance, power efficiency, and scalability demands of AI-driven data center networks. Built on Credo's advanced sixth-generation DSP architecture, the Robin 800G and 400G devices deliver enhanced signal integrity, reduced power consumpt

    3/17/26 9:00:00 AM ET
    $CRDO
    Semiconductors
    Technology

    Credo Introduces Cardinal: A Low‑Power 1.6T Optical DSP Family Engineered for Massive‑Scale AI Fabrics

    Features World-Class Energy Efficiency in a Highly Integrated Design Credo Technology Group Holding Ltd (Credo) (NASDAQ:CRDO), an innovator in providing connectivity at scale through fast, reliable, and energy-efficient system solutions, today announced Cardinal, a groundbreaking family of 3nm low‑power, highly integrated 224G/lane optical DSPs designed specifically to meet the explosive bandwidth, latency, and reliability demands of modern AI compute fabrics. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260317077875/en/Credo's Cardinal 1.6T optical DSP family addresses the bandwidth, scale, and power requirements of massive

    3/17/26 9:00:00 AM ET
    $CRDO
    Semiconductors
    Technology

    $AGX
    $BRZE
    $CRDO
    $CVNA
    SEC Filings

    View All

    $AGX
    $BRZE
    $CRDO
    $CVNA
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    $AGX
    $BRZE
    $CRDO
    $CVNA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 20-F filed by ODDITY Tech Ltd.

    20-F - Oddity Tech Ltd (0001907085) (Filer)

    3/17/26 4:20:24 PM ET
    $ODD
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form SCHEDULE 13G filed by Yext Inc.

    SCHEDULE 13G - Yext, Inc. (0001614178) (Subject)

    3/16/26 4:45:12 PM ET
    $YEXT
    EDP Services
    Technology

    SEC Form DEFA14A filed by Carvana Co.

    DEFA14A - CARVANA CO. (0001690820) (Filer)

    3/13/26 9:05:16 AM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    June 7, 2024 - FDA Roundup: June 7, 2024

    For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu

    6/7/24 3:46:22 PM ET
    $GERN
    $SRAX
    $SNAP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Advertising
    Consumer Discretionary

    FDA Approval for RYTELO issued to GERON CORP

    Submission status for GERON CORP's drug RYTELO (ORIG-1) with active ingredient IMETELSTAT has changed to 'Approval' on 06/06/2024. Application Category: NDA, Application Number: 217779, Application Classification: Type 1 - New Molecular Entity

    6/7/24 12:36:59 PM ET
    $GERN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for NEXLIZET issued to ESPERION THERAPS INC

    Submission status for ESPERION THERAPS INC's drug NEXLIZET (SUPPL-16) with active ingredient BEMPEDOIC ACID; EZETIMIBE has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211617, Application Classification: Efficacy

    3/25/24 4:41:30 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Koenig Sheldon L.

    4 - Esperion Therapeutics, Inc. (0001434868) (Issuer)

    3/18/26 4:13:23 PM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Looker Benjamin

    4 - Esperion Therapeutics, Inc. (0001434868) (Issuer)

    3/18/26 4:13:45 PM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Halladay Benjamin

    4 - Esperion Therapeutics, Inc. (0001434868) (Issuer)

    3/18/26 4:12:52 PM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGX
    $BRZE
    $CRDO
    $CVNA
    Leadership Updates

    Live Leadership Updates

    View All

    The $17 Billion Solar Maintenance Market Just Got a New Player From the Defense Sector

    Issued on behalf of VisionWave Holdings, Inc. Companies mentioned in this article: VisionWave Holdings (NASDAQ:VWAV), First Solar (NASDAQ:FSLR), Enphase Energy (NASDAQ:ENPH), SunPower (NASDAQ:SPWR), SolarEdge Technologies (NASDAQ:SEDG) Key Takeaways: VisionWave Holdings (NASDAQ:VWAV) subsidiary SolarDrone has acquired a 51% controlling interest in Junko Solar, an Israeli solar panel maintenance and cleaning company, and appointed its founder Amos Cohen as SolarDrone CEO.The global solar panel operation and maintenance market is valued at $17 billion in 2026 and projected to reach nearly $60 billion by 2035, growing at a 13.3% CAGR[1].First Solar inaugurated a $1.1 billion AI-enabled manuf

    3/17/26 9:00:00 AM ET
    $ENPH
    $FSLR
    $SEDG
    Semiconductors
    Technology
    Computer Software: Prepackaged Software

    Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600

    NEW YORK, March 6, 2026 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices: NAPCO Security Technologies Inc. (NASD: NSSC) will replace Alexander & Baldwin Inc. (NYSE:ALEX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, March 13. An investor group comprised of MW Group and funds affiliated with DivcoWest and Blackstone Real Estate is acquiring Alexander & Baldwin in a deal that is expected to close soon, pending final closing conditions.The following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 will take effect before the market opens on M

    3/6/26 6:39:00 PM ET
    $AGX
    $AHRT
    $AIG
    Engineering & Construction
    Consumer Discretionary
    Real Estate
    Finance

    Credo's Toucan PCIe Retimer Achieves PCI‑SIG® Compliance

    Credo Technology Group Holding Ltd (Credo) (NASDAQ:CRDO), an innovator in providing connectivity at scale through fast, reliable, and energy-efficient system solutions, announced that its PCIe® 6.0 technology-capable Toucan PCIe retimer has earned PCI-SIG® compliance at 32.0 GT/s. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260210132002/en/Credo's PCIe® 6.0 technology-capable Toucan PCIe retimer has earned PCI-SIG® compliance at 32.0 GT/s. This validation enables customers to deploy Toucan confidently in PCIe 6.0 technology and previous generation systems, avoiding compatibility and debugging challenges common with legacy-onl

    2/10/26 9:00:00 AM ET
    $CRDO
    Semiconductors
    Technology

    $AGX
    $BRZE
    $CRDO
    $CVNA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Carvana Co.

    SC 13D/A - CARVANA CO. (0001690820) (Subject)

    12/16/24 6:13:26 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by ODDITY Tech Ltd.

    SC 13G/A - Oddity Tech Ltd (0001907085) (Subject)

    11/18/24 9:49:27 PM ET
    $ODD
    Package Goods/Cosmetics
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by ODDITY Tech Ltd.

    SC 13G/A - Oddity Tech Ltd (0001907085) (Subject)

    11/14/24 6:38:27 PM ET
    $ODD
    Package Goods/Cosmetics
    Consumer Discretionary

    $AGX
    $BRZE
    $CRDO
    $CVNA
    Financials

    Live finance-specific insights

    View All

    Waldencast Reports Q4 2025 and FY 2025 Financial Results

    FY 2025 net revenue of $272.1 million, flat to FY 2024, and Adjusted EBITDA of $16.1 million Q4 2025 net revenue of $72.0 million, flat to Q4 2024 and Adjusted EBITDA of $6.6 million Obagi Medical sees continued revenue acceleration as a result of transformation efforts and continued brand momentum, alongside investments supporting the recent launch of its injectables platform Milk Makeup maintains U.S. consumption growth through distribution expansion, offset by softness in international markets Waldencast advanced its strategic priorities in 2025, entering medical aesthetics, and strengthening its financial flexibility through the sale of the Obagi Japan trademark and the refinancing o

    3/13/26 6:50:00 AM ET
    $WALD
    Package Goods/Cosmetics
    Consumer Discretionary

    Limoneira Company Announces First Quarter Fiscal Year 2026 Financial Results

    Total Costs and Expenses Decline 27% Year-Over-Year Reflecting Disciplined Execution of Operational Transformation; Tracking Toward $10 Million in Targeted Annual Selling, General and Administrative Savings Company Reiterates Avocado and Lemon Volume Guidance for Full Year Fiscal 2026 Near-Term Water Monetization Expected in Fiscal Year 2026 as Company Advances Water Value Creation Strategy Limoneira Company (the "Company" or "Limoneira") (NASDAQ:LMNR), a diversified lemon and avocado growing and lemon packing company with related agribusiness activities and real estate development operations, today reported financial results for the first quarter ended January 31, 2026. The Company

    3/12/26 4:27:00 PM ET
    $LMNR
    Farming/Seeds/Milling
    Consumer Staples

    Argan, Inc. to Announce Fourth Quarter and Fiscal Year-End 2026 Results and Host Conference Call on Thursday, March 26, 2026

    Argan, Inc. (NYSE:AGX) ("Argan" or the "Company") today announced that the Company will release its fourth quarter and fiscal year-end 2026 financial results after the market closes on Thursday, March 26, 2026. Management will host a webcast with an accompanying slide presentation and conference call on Thursday, March 26, 2026 at 5:00 p.m. ET. Participants can access the live webcast by visiting this link. To access the call by phone, participants can use the following dial-in information: Domestic: 888-506-0062 International: 973-528-0011 Access code: 815489 A replay of the teleconference will be available until April 9, 2026, and can be accessed by dialing 877-481-4010 (dom

    3/12/26 8:30:00 AM ET
    $AGX
    Engineering & Construction
    Consumer Discretionary